Cargando…

Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis

Detalles Bibliográficos
Autores principales:	Raghunandan, Sharmila, Gorfinkel, Lev, Bratrude, Brandi, Suessmuth, Yvonne, Hebert, Kyle, Neuberg, Donna, Williams, Kirsten M., Schoettler, Michelle L., Langston, Amelia A., Kean, Leslie S., Qayed, Muna, Horan, John, Watkins, Benjamin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622310/ https://www.ncbi.nlm.nih.gov/pubmed/37580396 http://dx.doi.org/10.1038/s41409-023-02034-z

Ejemplares similares

Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure
por: Stenger, Elizabeth O., et al.
Publicado: (2023)

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation
por: Qayed, Muna, et al.
Publicado: (2022)

Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia
por: Punwani, Nathan, et al.
Publicado: (2018)

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis
por: Tie, Ruxiu, et al.
Publicado: (2017)

The Impact of HLA and KIR Ligand Mismatching on Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Korean Adult Patients
por: Park, Hyewon, et al.
Publicado: (2015)

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation
por: Mayor, Neema P., et al.
Publicado: (2021)

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
por: Ruggeri, Annalisa, et al.
Publicado: (2022)

Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant
por: Jimenez Jimenez, Antonio, et al.
Publicado: (2022)

P1364: HLA MISMATCHED UNRELATED STEM CELL TRANSPLANTATION USING ANTITHYMOCYTE GLOBULIN IS A SUITABLE ALTERNATIVE FOR PATIENTS LACKING HLA-MATCHED UNRELATED DONORS: SINGLE CENTER LONG-TERM FOLLOW-UP DATA ANAL
por: Wang, L., et al.
Publicado: (2022)

Protective Effect of HLA-DPB1 Mismatch Remains Valid in Reduced-Intensity Conditioning Unrelated Donor Hematopoietic Cell Transplantation
por: Malki, Monzr M. Al, et al.
Publicado: (2019)

Decision analysis for donor selection in stem cell transplantation—HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor
por: Kanda, J, et al.
Publicado: (2014)

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders
por: Woolfrey, Ann, et al.
Publicado: (2018)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

2136: Gut microbiome alterations in children undergoing hematopoietic stem cell transplantation
por: Qayed, Muna, et al.
Publicado: (2018)

Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation
por: Janardan, Sanyukta, et al.
Publicado: (2022)

Soluble HLA Technology as a Strategy to Evaluate the Impact of HLA Mismatches
por: Kunze-Schumacher, Heike, et al.
Publicado: (2014)

A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity
por: Wiebe, Chris, et al.
Publicado: (2018)

Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis
por: Hirose, Wataru, et al.
Publicado: (2021)

HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
por: Tiercy, Jean-Marie
Publicado: (2014)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
por: Bacigalupo, Andrea, et al.
Publicado: (2016)

Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis
por: Inoue, Mariko, et al.
Publicado: (2023)

Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
por: Schoettler, Michelle, et al.
Publicado: (2022)

Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation
por: Iwasaki, Makoto, et al.
Publicado: (2022)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)

Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011)

A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation
por: Lee, Myung-Won, et al.
Publicado: (2020)

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
por: Park, Meerim, et al.
Publicado: (2011)

The novel HLA‐A*24 allele, HLA‐A*24:487, identified in three unrelated bone marrow donors in Colombia
por: Hernández, David Guillermo, et al.
Publicado: (2021)

T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity
por: Lum, Su Han, et al.
Publicado: (2022)

Subcutaneous abatacept for the treatment of rheumatoid arthritis
por: Schiff, Michael
Publicado: (2013)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Influence of HLA-DQ2.5 Dose on Clinical Picture of Unrelated Celiac Disease Patients
por: Airaksinen, Laura, et al.
Publicado: (2020)

Single nucleotide polymorphisms within HLA region are associated with the outcomes of unrelated cord blood transplantation
por: Chen, Ding-Ping, et al.
Publicado: (2021)

The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation
por: Dybko, Jarosław, et al.
Publicado: (2023)

Pediatric cholecystectomy for symptomatic gallstones unrelated to hematologic disorder
por: Suh, Sang Gyun, et al.
Publicado: (2016)

Allorecognition of HLA-C Mismatches by CD8(+) T Cells in Hematopoietic Stem Cell Transplantation Is a Complex Interplay between Mismatched Peptide-Binding Region Residues, HLA-C Expression, and HLA-DPB1 Disparities
por: Bettens, Florence, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bbi2h3ej5m1dj2pvbflge2qp84